Birgit Grund

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial”.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00751-9

N/A

6.2DataRank · unranked

194 citations

Uriel Sandkovsky, Cavan S. Reilly, David M. Vock, Robert L. Gottlieb, Michael Mack +95 more

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Annals of Internal Medicine(2021)10.7326/m21-3507

N/A

3.8DataRank · unranked

76 citations

Jens Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L Holland, Robert L. Gottlieb +88 more

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

The Lancet(2022)10.1016/s0140-6736(22)00101-5

N/A

3.1DataRank · unranked

77 citations

Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu +83 more

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00147-9

N/A

0.869DataRank · unranked

19 citations

Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew Phillips, Lindsay Leither +95 more

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned

Annals of Internal Medicine(2024)10.7326/annals-24-00464

N/A

0.574DataRank · unranked

45 citations

Alice K. Pau, Eric S. Daar, Laura Evans, Rajesh T. Gandhi, Pablo Tebas +61 more

Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

The Lancet Microbe(2024)10.1016/s2666-5247(24)00015-6

N/A

0.292DataRank · unranked

6 citations

Thomas A Murray, Greg A Grandits, Mamta K Jain, Birgit Grund, Kathryn Shaw-Saliba +94 more

Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV

AIDS(2022)10.1097/qad.0000000000003427

N/A

0.269DataRank · unranked

5 citations

Birgit Grund, Cameron Ross MacPherson, Christina Ekenberg, Adrian G. Zucco, Joanne Reekie +10 more

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad446

N/A

0.241DataRank · unranked

4 citations

Greg Grandits, Mamta K. Jain, Thomas A. Murray, Birgit Grund, Kathryn Shaw‐Saliba +93 more

The statistical design and analysis of pandemic platform trials: Implications for the future

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.514

N/A

0.165DataRank · unranked

2 citations

Matthew Shotwell, Kevin J. Anstrom, Scott Berry, Erica Brittain, Frank E. Harrell +13 more

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202112-2836oc

N/A

0DataRank · unranked

13 citations

Lianne Siegel, Greg Grandits, Andrew Phillips, Neil R. Aggarwal, Jason V. Baker +25 more

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciad780

N/A

0DataRank · unranked

16 citations

Jacquie Nordwall, Dominique L. Braun, Lucy Chung, Jordan Coslet, Tatyana Der +93 more

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)

Clinical Trials(2021)10.1177/17407745211049829

N/A

0DataRank · unranked

34 citations

Abdel G. Babiker, Jason V. Baker, Christina E. Barkauskas, Samuel M. Brown, Christina C. Chang +23 more

Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf327

N/A

0DataRank · unranked

1 citations

Nayon Kang, Lucy Chung, Courtney V. Fletcher, Page Crew, Jacqueline Nordwall +18 more

Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect

UNC Libraries(2020)10.17615/2t3q-gs93

N/A

0DataRank · unranked

0 citations

Jennifer Hoy, Richard W. Price, Michael J. Vjecha, Margaret P. Bain, Bruce J. Brew +5 more